AFP2 years ago
US becomes first country to approve Respiratory Syncytial Virus (RSV) vaccine
The US has approved the world's first vaccine for Respiratory Syncytial Virus (RSV), with drugmaker GSK's Arexvy being green-lighted for adults aged 60 and older. RSV...
